| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/19/2013 | CA2520400C Treatment of aspergillus infections with thymosin alpha 1 |
| 02/19/2013 | CA2512780C Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications |
| 02/19/2013 | CA2487137C Tumour-associated peptides that bind to mhc molecules |
| 02/19/2013 | CA2469092C Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als) |
| 02/19/2013 | CA2448382C Use of hepcidin as a regulator of iron homeostasis |
| 02/19/2013 | CA2388003C Expression of recombinant mature lysostaphin |
| 02/19/2013 | CA2375320C Dna vaccines for pets or for animals used in sports |
| 02/19/2013 | CA2372947C Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue |
| 02/19/2013 | CA2276450C A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/19/2013 | CA2233570C Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/19/2013 | CA2200541C Lhrh-antagonists in the treatment of fertility disorders |
| 02/14/2013 | WO2013023166A2 Hapivirins and diprovirins |
| 02/14/2013 | WO2013022991A2 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 02/14/2013 | WO2013022982A2 Pegylated tyrosyl-trna synthetase polypeptides |
| 02/14/2013 | WO2013022829A2 Endomucin as an anti-inflammatory agent |
| 02/14/2013 | WO2013022763A1 Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains |
| 02/14/2013 | WO2013022738A1 P97 fragments with transfer activity |
| 02/14/2013 | WO2013022721A1 N-glycosylated insulin analogues |
| 02/14/2013 | WO2013022692A1 Methods and compositions for inhibiting delayed graft function |
| 02/14/2013 | WO2013022447A1 Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
| 02/14/2013 | WO2013022354A1 Methods and compositions for improving sperm functionality |
| 02/14/2013 | WO2013022262A2 Human resistin receptor, and use thereof |
| 02/14/2013 | WO2013022157A1 Pharmaceutical composition containing fibulin-3 protein as an active ingredient for inhibiting the growth of cancer stem cells |
| 02/14/2013 | WO2013022091A1 Therapeutic agent for autoimmune diseases comprising pd-1 agonist |
| 02/14/2013 | WO2013022058A1 Bilirubin excretion enhancer |
| 02/14/2013 | WO2013021377A1 Novel peptides, compositions comprising the same and uses thereof in methods for the treatment of metabolic, cardiac and immune-related disorders |
| 02/14/2013 | WO2013021359A1 Method for dissolution testing of solid compositions containing digestive enzymes |
| 02/14/2013 | WO2013021196A2 Oligodendrocyte differentiation |
| 02/14/2013 | WO2013021143A1 Injectable solution of at least one type of basal insulin |
| 02/14/2013 | WO2013021093A1 Use of cardiotrophin-1 for the treatment of kidney diseases |
| 02/14/2013 | WO2013020996A1 Composition for controlled ovarian stimulation |
| 02/14/2013 | WO2013020898A1 Constitutively active upar variants and their use for the generation and isolation of inhibitory antibodies |
| 02/14/2013 | WO2013020372A1 Methods and reagents for preventing and curing insulin resistance and diabetes mellitus |
| 02/14/2013 | WO2013020366A1 The use of ache as nuclease |
| 02/14/2013 | WO2013020235A1 Methods and compositions for modulating voltage-gated calcium channel function |
| 02/14/2013 | WO2012177020A9 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
| 02/14/2013 | WO2012169798A3 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same |
| 02/14/2013 | WO2012166588A3 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
| 02/14/2013 | WO2012134897A8 Treatment of sensory disturbance disorders |
| 02/14/2013 | WO2012128502A3 Composition for promoting vasculogenesis comprising pauf |
| 02/14/2013 | WO2012097238A3 Il-27 antagonists for treating inflammatory diseases |
| 02/14/2013 | WO2012082056A8 Novel biomarker and uses thereof in diagnosis, treatment of autism |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130041418 Methods for treating pulmonary hypertension and compositions comprising vasoactive intestinal peptide |
| 02/14/2013 | US20130041307 Application of beta-functionalized dihydroxy-chlorins for pdt |
| 02/14/2013 | US20130041210 Process for the Synchronization of Ovulation for Timed Breeding Without Heat Detection |
| 02/14/2013 | US20130041137 von Willebrand Factor (vWF) - Cleaving Protease |
| 02/14/2013 | US20130040901 Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy |
| 02/14/2013 | US20130040900 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2013 | US20130040899 Use of PEDF-Derived Polypeptides for Treating Liver Cirrhosis |
| 02/14/2013 | US20130040898 Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof |
| 02/14/2013 | US20130040897 Glycosylation of proteins in host cells |
| 02/14/2013 | US20130040896 Methods and compositions for modulating angiogenesis and pericyte composition |
| 02/14/2013 | US20130040895 Pharmaceutical Formulations and Methods for Treating Ocular Conditions |
| 02/14/2013 | US20130040894 Inhibition or activation of serine/threonine ulk3 kinase activity |
| 02/14/2013 | US20130040893 Treatment of proliferative disorders |
| 02/14/2013 | US20130040892 Iap bir domain binding compounds |
| 02/14/2013 | US20130040890 Lyophilization methods, compositions, and kits |
| 02/14/2013 | US20130040889 Factor VIII Fusion Protein |
| 02/14/2013 | US20130040888 Factor VIII Molecules With Reduced VWF Binding |
| 02/14/2013 | US20130040887 Inhibiting Collagen-Induced Platelet Aggregation and Activation with Peptide Variants |
| 02/14/2013 | US20130040886 Peptides and Methods for Inhibiting G alpha Protein Signaling |
| 02/14/2013 | US20130040885 Collagen pad |
| 02/14/2013 | US20130040884 Albumin-binding conjugates comprising fatty-acid and peg |
| 02/14/2013 | US20130040883 Stable growth hormone compounds |
| 02/14/2013 | US20130040882 Use of fibroblast growth factor fragments |
| 02/14/2013 | US20130040881 Ltbp2 as a biomarker for renal dysfunction |
| 02/14/2013 | US20130040880 Novel Cytokine Containing Compositions |
| 02/14/2013 | US20130040879 Methods For Treating Congestive Heart Failure |
| 02/14/2013 | US20130040878 Pharmaceutical combination for use in the treatment of diabetes type 2 patients |
| 02/14/2013 | US20130040877 Long-acting y2 receptor agonists |
| 02/14/2013 | US20130040876 Method for sensitizing cells to cancer therapy |
| 02/14/2013 | US20130039986 Silk-Based Ionomeric Compositions |
| 02/14/2013 | US20130039977 Pharmaceutical composition, a method of preparing it and a method of treatment by use thereof |
| 02/14/2013 | US20130039972 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 02/14/2013 | US20130039970 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics |
| 02/14/2013 | US20130039953 Method for treating a surface with a coating comprising a therapeutic agent and device with treated surface |
| 02/14/2013 | US20130039948 Inhibition of TCR Signaling with Peptide Variants |
| 02/14/2013 | US20130039939 Lipopeptide- and lipoprotein-conjugates and its use |
| 02/14/2013 | US20130039930 Biomarker for sensitivity to therapy with a notch inhibitor |
| 02/14/2013 | US20130039924 Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039903 Eczema treatment |
| 02/14/2013 | US20130039902 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/14/2013 | US20130039901 Treatment of Pompe's Disease |
| 02/14/2013 | US20130039900 Compositions and methods for altering cocaine esterase activity |
| 02/14/2013 | US20130039899 Methods and devices for applying tissue sealants and adhesives |
| 02/14/2013 | US20130039898 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof |
| 02/14/2013 | US20130039897 Compositions and methods for regulating neutrophil movement and neutrophil numbers in a body region |
| 02/14/2013 | US20130039894 Polypeptides and Use Thereof for Treatment of Traumatic or Degenerative Neuronal Injury |
| 02/14/2013 | US20130039890 Treatment of tumors with genetically engineered herpes virus |
| 02/14/2013 | US20130039889 Recombinant microorganisms |
| 02/14/2013 | US20130039887 Methods of Identifying and Using Anti-Viral Compounds |
| 02/14/2013 | US20130039886 Beta-mannosylceramide and stimulation of nkt cell anti-tumor immunity |
| 02/14/2013 | US20130039885 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/14/2013 | US20130039883 Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment |
| 02/14/2013 | US20130039882 Method to mitigate injury from radiation exposure |
| 02/14/2013 | US20130039879 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 02/14/2013 | US20130039878 Triple cross-linked collagen, method of manufacturing the same, and use thereof |
| 02/14/2013 | US20130039856 Products and Methods |